Literature DB >> 19871580

STUDIES ON HERPETIC INFECTION IN MICE : IV. THE EFFECT OF SPECIFIC ANTIBODIES ON THE PROGRESSION OF THE VIRUS WITHIN THE NERVOUS SYSTEM OF YOUNG MICE.

C A Evans1, H B Slavin, G P Berry.   

Abstract

Two-week-old mice inoculated with herpes virus on the pad of a hind foot regularly developed paralysis of the infected limb followed by paraplegia and encephalitis terminating fatally 5 or 6 days after inoculation. Hyperimmune rabbit serum given intraperitoneally at the time virus was inoculated on the foot pad prevented the formation of an herpetic lesion of the foot pad. When the antiserum was given 12 hours after inoculation of the virus, a typical infection of the epithelium of the foot pad developed, but the virus was prevented from causing obvious signs of infection of the nervous system in many of the animals. Amputation of the foot 2 hours after the inoculation of the virus prevented the paralysis of the hind leg. Some of the mice died of a delayed encephalitis. Amputation of the foot at 24 hours neither prevented nor delayed the sequence of paralysis of the hind leg, encephalitis, and death. In order to study immune serum therapy of an infection of the nervous system uncomplicated by a peripheral focus of infection or by traumatic disturbance of the central nervous system, 2-week-old mice were inoculated on the foot pad, the infected feet were amputated 24 hours later, and the immune serum was administered at varying intervals thereafter. Using litter mate controls and statistically significant numbers of mice, it was shown that hyperimmune rabbit serum, administered during the first one-third of the incubation period, retards and, in some cases, arrests the progress of herpetic infection within the nervous system.

Entities:  

Keywords:  HERPES/immunity; NERVOUS SYSTEM/diseases; VIRUSES/diseases

Mesh:

Substances:

Year:  1946        PMID: 19871580      PMCID: PMC2135659          DOI: 10.1084/jem.84.5.429

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  Successful Treatment of Experimental Western Equine Encephalomyelitis with Hyperimmune Rabbit Serum.

Authors:  J Zichis; H J Shaughnessy
Journal:  Am J Public Health Nations Health       Date:  1945-08

2.  STUDIES ON HERPETIC INFECTION IN MICE : III. THE VISCERAL LESIONS IN SUCKLING MICE.

Authors:  H B Slavin; G P Berry
Journal:  J Exp Med       Date:  1943-10-01       Impact factor: 14.307

3.  STUDIES ON HERPETIC INFECTION IN MICE : I. PASSIVE PROTECTION AGAINST VIRUS INOCULATED INTRANASALLY.

Authors:  G P Berry; H B Slavin
Journal:  J Exp Med       Date:  1943-10-01       Impact factor: 14.307

4.  STUDIES ON HERPETIC INFECTION IN MICE : II. THE PATHWAYS OF INVASION OF THE CENTRAL NERVOUS SYSTEM AFTER INTRANASAL INSTILLATION OF VIRUS IN SUCKLING MICE.

Authors:  H B Slavin; G P Berry
Journal:  J Exp Med       Date:  1943-10-01       Impact factor: 14.307

5.  PASSIVE IMMUNITY TO POLIOMYELITIS IN THE CHIMPANZEE.

Authors:  H A Howe; D Bodian
Journal:  J Exp Med       Date:  1945-03-01       Impact factor: 14.307

6.  INDUCED RESISTANCE OF THE CENTRAL NERVOUS SYSTEM TO EXPERIMENTAL INFECTION WITH EQUINE ENCEPHALOMYELITIS VIRUS : II. SEROTHERAPY IN WESTERN VIRUS INFECTION.

Authors:  P K Olitsky; R W Schlesinger; I M Morgan
Journal:  J Exp Med       Date:  1943-04-01       Impact factor: 14.307

  6 in total
  3 in total

1.  The protective effect of different immunoglobulins against herpetic encephalitis and skin infection in guinea pigs.

Authors:  T Tokumaru
Journal:  Arch Gesamte Virusforsch       Date:  1967

2.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

3.  Studies on herpetic infection in mice. V. Influence of route of inoculation on susceptibility to herpetic infection; effect of age, and of methylcholanthrene.

Authors:  C A EVANS; H B SLAVIN; G P BERRY
Journal:  J Exp Med       Date:  1950-05-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.